BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36960123)

  • 1. Impacts of Outpatient Payment Reforms on Volume and Expenditures in Public Hospitals: Evidence from a Quasi-Experimental Analysis in Zhejiang, China.
    Zhang T; Lu B; Song Y; Chen M
    Risk Manag Healthc Policy; 2023; 16():415-424. PubMed ID: 36960123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. County Hospital Responses to Funding Reforms in Zhejiang, China: An Interrupted Time-Series Analysis.
    Zhang T; Liu J; Wang X; Liu C
    Health Syst Reform; 2023 Dec; 9(1):2258770. PubMed ID: 37788424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of a New Episode-Based Payment Scheme on Volume, Expenditures, and Efficiency in Public Hospitals: A Quasi-Experimental Interrupted Time-Series Study in Jinhua, China.
    Zhang T; Lu B; Yan Z; Huang X; Lu W
    Risk Manag Healthc Policy; 2022; 15():1659-1669. PubMed ID: 36092550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of China's healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study.
    Zhu D; Shi X; Nicholas S; Bai Q; He P
    BMJ Open; 2019 Aug; 9(8):e029646. PubMed ID: 31401602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intended and unintended impacts of the comprehensive reform of urban public hospitals: A mixed-method study in Hangzhou, China.
    Zhang T; Liu J; Lu B; Yan Z; Huang X; Lu W
    Front Public Health; 2022; 10():979455. PubMed ID: 36299745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and expenses of outpatient services among tuberculosis patients in three Chinese counties: an observational comparison study.
    Wang XX; Chen JY; Jiang H; Zhu AN; Long Q; Ji JS
    Infect Dis Poverty; 2019 Oct; 8(1):79. PubMed ID: 31581953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in the impact of the new case-based payment reform on medical costs, length of stay, and quality across different hospitals in China: an interrupted time series analysis.
    Tang X; Zhang X; Chen Y; Yan J; Qian M; Ying X
    BMC Health Serv Res; 2023 Jun; 23(1):568. PubMed ID: 37264450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the National Centralized Drug Procurement Policy (4 + 7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level-A hospital in China: A single centre, interrupted time series.
    Lan T; Guan L; Pang X; Li X; Yu Q
    J Clin Pharm Ther; 2022 Jan; 47(1):104-111. PubMed ID: 34668203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term and long-term effects of Sanming healthcare system reform on drug-related expenditures for rural patients with cancer in public hospitals: an interrupted time series analysis using segmented regression model in China.
    Fu R; Chen Q; Lin Y; Lin Z; Zheng Z; Hu Z
    BMJ Open; 2023 Jan; 13(1):e065586. PubMed ID: 36604122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the zero-mark-up drug policy on drug-related expenditures and use in public hospitals, 2016-2018: an interrupted time series study in Shaanxi.
    Yan K; Yang C; Zhang H; Ye D; Liu S; Chang J; Jiang M; Zhao M; Fang Y
    BMJ Open; 2020 Nov; 10(11):e037034. PubMed ID: 33243788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of medical consortium policy on health services: an interrupted time-series analysis in Sanming, China.
    Yang X; Chen Y; Li C; Hao M
    Front Public Health; 2024; 12():1322949. PubMed ID: 38327577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Payment methods for outpatient care facilities.
    Yuan B; He L; Meng Q; Jia L
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011153. PubMed ID: 28253540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impacts of diagnosis-intervention packet payment on the providers' behavior of inpatient care-evidence from a national pilot city in China.
    Ding Y; Yin J; Zheng C; Dixon S; Sun Q
    Front Public Health; 2023; 11():1069131. PubMed ID: 37325323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of healthcare system reforms on public hospitals' revenue structures: Evidence from Beijing, China.
    Gao L; Shi L; Meng Q; Kong X; Guo M; Lu F
    Soc Sci Med; 2021 Aug; 283():114210. PubMed ID: 34274783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of capitation prepayment on the medical expenses and health service utilization of patients with coronary heart disease: a community policy intervention program in a county in China.
    Yan J; Shi Y; Zhang J; Chen S; Huo X; Shen Y; Zhang N
    BMC Public Health; 2023 Nov; 23(1):2224. PubMed ID: 37950184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Chinese medical pricing reform on the structure of hospital revenue and healthcare expenditure in county hospital: an interrupted time series analysis.
    Liu M; Jia M; Lin Q; Zhu J; Wang D
    BMC Health Serv Res; 2021 Apr; 21(1):385. PubMed ID: 33902578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China.
    Peng Z; Zhan C; Ma X; Yao H; Chen X; Sha X; Coyte PC
    BMC Health Serv Res; 2021 Nov; 21(1):1205. PubMed ID: 34742310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital response to a case-based payment scheme under regional global budget: The case of Guangzhou in China.
    Lai Y; Fu H; Li L; Yip W
    Soc Sci Med; 2022 Jan; 292():114601. PubMed ID: 34844079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis.
    Wang J; Li P; Wen J
    BMC Health Serv Res; 2020 Jun; 20(1):519. PubMed ID: 32513170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan.
    Chen LC; Schafheutle EI; Noyce PR
    Res Social Adm Pharm; 2009 Sep; 5(3):211-24. PubMed ID: 19733822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.